https://www.bloomberg.com/news/articles/2021-05-27/china-s-sinopharm-publishes-awaited-covid-vaccine-study-details
Vaccines from China’s Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literature.
China’s Sinopharm Publishes Awaited Covid Vaccine Study Details
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Redfin Reports 28% of Houses For Sale Are Newly Built, the Lowest Share in 3 Years
- Real Estate Agent Commissions Hold Steady Since New Industry Rules Were Implemented, Redfin Reports
- Redfin Reports Housing Market Stays Surprisingly Active As Election Looms and Mortgage Rates Hit 7%
- Buying like it’s 2021: Nearly half of recent buyers have a mortgage rate below 5%
- Switzerland SVME
- How to use generative AI to reduce friction and convert car buyers
- Get more out of your webinars and virtual events with 24/7 engagement by Edna Chavira
- Is it time to clean out your martech stack?
- Beyond the funnel: A new approach to content marketing
- What Are the Hardest Positions to Fill Right Now?
More from UncategorizedMore posts in Uncategorized »
- Redfin Reports 28% of Houses For Sale Are Newly Built, the Lowest Share in 3 Years
- Real Estate Agent Commissions Hold Steady Since New Industry Rules Were Implemented, Redfin Reports
- Redfin Reports Housing Market Stays Surprisingly Active As Election Looms and Mortgage Rates Hit 7%
- Buying like it’s 2021: Nearly half of recent buyers have a mortgage rate below 5%
- Switzerland SVME
- How to use generative AI to reduce friction and convert car buyers
- Get more out of your webinars and virtual events with 24/7 engagement by Edna Chavira
- Is it time to clean out your martech stack?
- Beyond the funnel: A new approach to content marketing
- What Are the Hardest Positions to Fill Right Now?